title: Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine.
authors.forename: A
authors.initials: A
authors.lastname: Bazarbachi
authors.forename: H
authors.initials: H
authors.lastname: Bachelez
authors.forename: L
authors.initials: L
authors.lastname: Dehen
authors.forename: A
authors.initials: A
authors.lastname: Delmer
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
authors.forename: L
authors.initials: L
authors.lastname: Dubertret
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000139:chemically induced*; D010392:Pemphigus / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine